Clindamycin Phosphate Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240995

Publication Date:

September 6, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Clindamycin Injection, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.
The global market for Clindamycin Phosphate Injection was estimated to be worth US$ 452 million in 2023 and is forecast to a readjusted size of US$ 662.9 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030
North American market for Clindamycin Phosphate Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clindamycin Phosphate Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Clindamycin Phosphate Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Clindamycin Phosphate Injection include Pfizer, Alvogen, Fresenius Kabi, West Ward Pharmaceutical, Sagent Pharmaceuticals, Mylan, FORWARD, CHANGCHUN LEI YUN SHANG PHARMACEUTICAL and EBANG, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clindamycin Phosphate Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Clindamycin Phosphate Injection by region & country, by Type, and by Application.
The Clindamycin Phosphate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clindamycin Phosphate Injection.
Market Segmentation
By Company
Pfizer
Alvogen
Fresenius Kabi
West Ward Pharmaceutical
Sagent Pharmaceuticals
Mylan
FORWARD
CHANGCHUN LEI YUN SHANG PHARMACEUTICAL
EBANG
ASK Pharma
Sinopharm Guorui Pharmaceutical
Segment by Type:
2ml Vial
4ml Vial
6ml Vial
Segment by Application
Adults
Pediatric patients 1 month of age to 16 years
Neonates (less than 1 month)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clindamycin Phosphate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Clindamycin Phosphate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Clindamycin Phosphate Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Clindamycin Phosphate Injection Product Introduction
1.2 Global Clindamycin Phosphate Injection Market Size Forecast
1.2.1 Global Clindamycin Phosphate Injection Sales Value (2019-2030)
1.2.2 Global Clindamycin Phosphate Injection Sales Volume (2019-2030)
1.2.3 Global Clindamycin Phosphate Injection Sales Price (2019-2030)
1.3 Clindamycin Phosphate Injection Market Trends & Drivers
1.3.1 Clindamycin Phosphate Injection Industry Trends
1.3.2 Clindamycin Phosphate Injection Market Drivers & Opportunity
1.3.3 Clindamycin Phosphate Injection Market Challenges
1.3.4 Clindamycin Phosphate Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clindamycin Phosphate Injection Players Revenue Ranking (2023)
2.2 Global Clindamycin Phosphate Injection Revenue by Company (2019-2024)
2.3 Global Clindamycin Phosphate Injection Players Sales Volume Ranking (2023)
2.4 Global Clindamycin Phosphate Injection Sales Volume by Company Players (2019-2024)
2.5 Global Clindamycin Phosphate Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Clindamycin Phosphate Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Clindamycin Phosphate Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Clindamycin Phosphate Injection
2.9 Clindamycin Phosphate Injection Market Competitive Analysis
2.9.1 Clindamycin Phosphate Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Clindamycin Phosphate Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clindamycin Phosphate Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 2ml Vial
3.1.2 4ml Vial
3.1.3 6ml Vial
3.2 Global Clindamycin Phosphate Injection Sales Value by Type
3.2.1 Global Clindamycin Phosphate Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clindamycin Phosphate Injection Sales Value, by Type (2019-2030)
3.2.3 Global Clindamycin Phosphate Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Clindamycin Phosphate Injection Sales Volume by Type
3.3.1 Global Clindamycin Phosphate Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Clindamycin Phosphate Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Clindamycin Phosphate Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Clindamycin Phosphate Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Pediatric patients 1 month of age to 16 years
4.1.3 Neonates (less than 1 month)
4.2 Global Clindamycin Phosphate Injection Sales Value by Application
4.2.1 Global Clindamycin Phosphate Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clindamycin Phosphate Injection Sales Value, by Application (2019-2030)
4.2.3 Global Clindamycin Phosphate Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Clindamycin Phosphate Injection Sales Volume by Application
4.3.1 Global Clindamycin Phosphate Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Clindamycin Phosphate Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Clindamycin Phosphate Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Clindamycin Phosphate Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Clindamycin Phosphate Injection Sales Value by Region
5.1.1 Global Clindamycin Phosphate Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clindamycin Phosphate Injection Sales Value by Region (2019-2024)
5.1.3 Global Clindamycin Phosphate Injection Sales Value by Region (2025-2030)
5.1.4 Global Clindamycin Phosphate Injection Sales Value by Region (%), (2019-2030)
5.2 Global Clindamycin Phosphate Injection Sales Volume by Region
5.2.1 Global Clindamycin Phosphate Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Clindamycin Phosphate Injection Sales Volume by Region (2019-2024)
5.2.3 Global Clindamycin Phosphate Injection Sales Volume by Region (2025-2030)
5.2.4 Global Clindamycin Phosphate Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Clindamycin Phosphate Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Clindamycin Phosphate Injection Sales Value, 2019-2030
5.4.2 North America Clindamycin Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Clindamycin Phosphate Injection Sales Value, 2019-2030
5.5.2 Europe Clindamycin Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Clindamycin Phosphate Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Clindamycin Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Clindamycin Phosphate Injection Sales Value, 2019-2030
5.7.2 South America Clindamycin Phosphate Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Clindamycin Phosphate Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Clindamycin Phosphate Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clindamycin Phosphate Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clindamycin Phosphate Injection Sales Value
6.2.1 Key Countries/Regions Clindamycin Phosphate Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Clindamycin Phosphate Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Clindamycin Phosphate Injection Sales Value, 2019-2030
6.3.2 United States Clindamycin Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clindamycin Phosphate Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clindamycin Phosphate Injection Sales Value, 2019-2030
6.4.2 Europe Clindamycin Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clindamycin Phosphate Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clindamycin Phosphate Injection Sales Value, 2019-2030
6.5.2 China Clindamycin Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clindamycin Phosphate Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clindamycin Phosphate Injection Sales Value, 2019-2030
6.6.2 Japan Clindamycin Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clindamycin Phosphate Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clindamycin Phosphate Injection Sales Value, 2019-2030
6.7.2 South Korea Clindamycin Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clindamycin Phosphate Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clindamycin Phosphate Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Clindamycin Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clindamycin Phosphate Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clindamycin Phosphate Injection Sales Value, 2019-2030
6.9.2 India Clindamycin Phosphate Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clindamycin Phosphate Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Clindamycin Phosphate Injection Product Offerings
7.1.5 Pfizer Recent Development
7.2 Alvogen
7.2.1 Alvogen Company Information
7.2.2 Alvogen Introduction and Business Overview
7.2.3 Alvogen Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alvogen Clindamycin Phosphate Injection Product Offerings
7.2.5 Alvogen Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Introduction and Business Overview
7.3.3 Fresenius Kabi Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Fresenius Kabi Clindamycin Phosphate Injection Product Offerings
7.3.5 Fresenius Kabi Recent Development
7.4 West Ward Pharmaceutical
7.4.1 West Ward Pharmaceutical Company Information
7.4.2 West Ward Pharmaceutical Introduction and Business Overview
7.4.3 West Ward Pharmaceutical Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 West Ward Pharmaceutical Clindamycin Phosphate Injection Product Offerings
7.4.5 West Ward Pharmaceutical Recent Development
7.5 Sagent Pharmaceuticals
7.5.1 Sagent Pharmaceuticals Company Information
7.5.2 Sagent Pharmaceuticals Introduction and Business Overview
7.5.3 Sagent Pharmaceuticals Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sagent Pharmaceuticals Clindamycin Phosphate Injection Product Offerings
7.5.5 Sagent Pharmaceuticals Recent Development
7.6 Mylan
7.6.1 Mylan Company Information
7.6.2 Mylan Introduction and Business Overview
7.6.3 Mylan Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mylan Clindamycin Phosphate Injection Product Offerings
7.6.5 Mylan Recent Development
7.7 FORWARD
7.7.1 FORWARD Company Information
7.7.2 FORWARD Introduction and Business Overview
7.7.3 FORWARD Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 FORWARD Clindamycin Phosphate Injection Product Offerings
7.7.5 FORWARD Recent Development
7.8 CHANGCHUN LEI YUN SHANG PHARMACEUTICAL
7.8.1 CHANGCHUN LEI YUN SHANG PHARMACEUTICAL Company Information
7.8.2 CHANGCHUN LEI YUN SHANG PHARMACEUTICAL Introduction and Business Overview
7.8.3 CHANGCHUN LEI YUN SHANG PHARMACEUTICAL Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.8.4 CHANGCHUN LEI YUN SHANG PHARMACEUTICAL Clindamycin Phosphate Injection Product Offerings
7.8.5 CHANGCHUN LEI YUN SHANG PHARMACEUTICAL Recent Development
7.9 EBANG
7.9.1 EBANG Company Information
7.9.2 EBANG Introduction and Business Overview
7.9.3 EBANG Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.9.4 EBANG Clindamycin Phosphate Injection Product Offerings
7.9.5 EBANG Recent Development
7.10 ASK Pharma
7.10.1 ASK Pharma Company Information
7.10.2 ASK Pharma Introduction and Business Overview
7.10.3 ASK Pharma Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.10.4 ASK Pharma Clindamycin Phosphate Injection Product Offerings
7.10.5 ASK Pharma Recent Development
7.11 Sinopharm Guorui Pharmaceutical
7.11.1 Sinopharm Guorui Pharmaceutical Company Information
7.11.2 Sinopharm Guorui Pharmaceutical Introduction and Business Overview
7.11.3 Sinopharm Guorui Pharmaceutical Clindamycin Phosphate Injection Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Sinopharm Guorui Pharmaceutical Clindamycin Phosphate Injection Product Offerings
7.11.5 Sinopharm Guorui Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Clindamycin Phosphate Injection Industrial Chain
8.2 Clindamycin Phosphate Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clindamycin Phosphate Injection Sales Model
8.5.2 Sales Channel
8.5.3 Clindamycin Phosphate Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Pfizer
Alvogen
Fresenius Kabi
West Ward Pharmaceutical
Sagent Pharmaceuticals
Mylan
FORWARD
CHANGCHUN LEI YUN SHANG PHARMACEUTICAL
EBANG
ASK Pharma
Sinopharm Guorui Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂